MAO-B Antibodies

Santa Cruz Biotechnology features a diverse variety of MAO-B monoclonal antibodies for investigating monoamine oxidase B in various biological processes. MAO-B monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Monoamine oxidase B is an essential enzyme that catalyzes the breakdown of neurotransmitters such as dopamine, significantly influencing mood regulation and cognitive functions. Research has shown that altered monoamine oxidase B levels are associated with neurodegenerative conditions, particularly Parkinson's disease and Alzheimer's disease. Investigating monoamine oxidase B expression and activity patterns can reveal crucial information about disease progression and potential therapeutic targets. MAO-B monoclonal antibodies enable precise detection and quantification of monoamine oxidase B in various experimental settings. Understanding the distribution and regulation of monoamine oxidase B across different tissues and cellular compartments provides valuable insights into its biological functions. Researchers worldwide rely on MAO-B monoclonal antibodies from Santa Cruz Biotechnology to advance scientific understanding of neurodegenerative disorders and contribute to therapeutic development.